AIM ImmunoTech Q1 2026 Earnings EPS Miss Widens as Clinical Pipeline Drives Higher Operating Costs Castle Biosciences Inc CSTL Q1 2026 Earnings NarrowerThanExpected Loss Drives Modest Optimism EPR Properties Q1 2026 Earnings Strong EPS Beat Drives Modest Stock Gain Credicorp BAP Q4 2025 Earnings EPS Misses Estimates Stock Declines on Profitability Pressure Kyndryl KD Q1 2026 Earnings EPS Misses Expectations Stock Rises Despite Surprise VSNT Q1 2026 Earnings EPS Surges Past Estimates with 949 Beat